Cargando…

Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement

Background: Although increasing cerebral perfusion pressure (CPP) is commonly accepted to improve brain tissue oxygen pressure (PbtO(2)), it remains unclear whether recommended CPP targets (i. e., >60 mmHg) would result in adequate brain oxygenation in brain injured patients. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovacs, Matyas, Peluso, Lorenzo, Njimi, Hassane, De Witte, Olivier, Gouvêa Bogossian, Elisa, Quispe Cornejo, Armin, Creteur, Jacques, Schuind, Sophie, Taccone, Fabio Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581172/
https://www.ncbi.nlm.nih.gov/pubmed/34777201
http://dx.doi.org/10.3389/fneur.2021.732830
_version_ 1784596747074404352
author Kovacs, Matyas
Peluso, Lorenzo
Njimi, Hassane
De Witte, Olivier
Gouvêa Bogossian, Elisa
Quispe Cornejo, Armin
Creteur, Jacques
Schuind, Sophie
Taccone, Fabio Silvio
author_facet Kovacs, Matyas
Peluso, Lorenzo
Njimi, Hassane
De Witte, Olivier
Gouvêa Bogossian, Elisa
Quispe Cornejo, Armin
Creteur, Jacques
Schuind, Sophie
Taccone, Fabio Silvio
author_sort Kovacs, Matyas
collection PubMed
description Background: Although increasing cerebral perfusion pressure (CPP) is commonly accepted to improve brain tissue oxygen pressure (PbtO(2)), it remains unclear whether recommended CPP targets (i. e., >60 mmHg) would result in adequate brain oxygenation in brain injured patients. The aim of this study was to identify the target of CPP associated with normal brain oxygenation. Methods: Prospectively collected data including patients suffering from acute brain injury and monitored with PbtO(2), in whom daily CPP challenge using vasopressors was performed. Initial CPP target was >60 mmHg; norepinephrine infusion was modified to have an increase in CPP of at least 10 mmHg at two different steps above the baseline values. Whenever possible, the same CPP challenge was performed for the following days, for a maximum of 5 days. CPP “responders” were patients with a relative increase in PbtO(2) from baseline values > 20%. Results: A total of 53 patients were included. On the first day of assessment, CPP was progressively increased from 73 (70–76) to 83 (80–86), and 92 (90–96) mmHg, which resulted into a significant PbtO(2) increase [from 20 (17–23) mmHg to 22 (20–24) mmHg and 24 (22–26) mmHg, respectively; p < 0.001]. Median CPP value corresponding to PbtO(2) values > 20 mmHg was 79 (74–87) mmHg, with 2 (4%) patients who never achieved such target. Similar results of CPP targets were observed the following days. A total of 25 (47%) were PbtO(2) responders during the CPP challenge on day 1, in particular if low PbtO(2) was observed at baseline. Conclusions: PbtO(2) monitoring can be an effective way to individualize CPP values to avoid tissue hypoxia. Low PbtO(2) values at baseline can identify the responders to the CPP challenge.
format Online
Article
Text
id pubmed-8581172
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85811722021-11-12 Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement Kovacs, Matyas Peluso, Lorenzo Njimi, Hassane De Witte, Olivier Gouvêa Bogossian, Elisa Quispe Cornejo, Armin Creteur, Jacques Schuind, Sophie Taccone, Fabio Silvio Front Neurol Neurology Background: Although increasing cerebral perfusion pressure (CPP) is commonly accepted to improve brain tissue oxygen pressure (PbtO(2)), it remains unclear whether recommended CPP targets (i. e., >60 mmHg) would result in adequate brain oxygenation in brain injured patients. The aim of this study was to identify the target of CPP associated with normal brain oxygenation. Methods: Prospectively collected data including patients suffering from acute brain injury and monitored with PbtO(2), in whom daily CPP challenge using vasopressors was performed. Initial CPP target was >60 mmHg; norepinephrine infusion was modified to have an increase in CPP of at least 10 mmHg at two different steps above the baseline values. Whenever possible, the same CPP challenge was performed for the following days, for a maximum of 5 days. CPP “responders” were patients with a relative increase in PbtO(2) from baseline values > 20%. Results: A total of 53 patients were included. On the first day of assessment, CPP was progressively increased from 73 (70–76) to 83 (80–86), and 92 (90–96) mmHg, which resulted into a significant PbtO(2) increase [from 20 (17–23) mmHg to 22 (20–24) mmHg and 24 (22–26) mmHg, respectively; p < 0.001]. Median CPP value corresponding to PbtO(2) values > 20 mmHg was 79 (74–87) mmHg, with 2 (4%) patients who never achieved such target. Similar results of CPP targets were observed the following days. A total of 25 (47%) were PbtO(2) responders during the CPP challenge on day 1, in particular if low PbtO(2) was observed at baseline. Conclusions: PbtO(2) monitoring can be an effective way to individualize CPP values to avoid tissue hypoxia. Low PbtO(2) values at baseline can identify the responders to the CPP challenge. Frontiers Media S.A. 2021-10-28 /pmc/articles/PMC8581172/ /pubmed/34777201 http://dx.doi.org/10.3389/fneur.2021.732830 Text en Copyright © 2021 Kovacs, Peluso, Njimi, De Witte, Gouvêa Bogossian, Quispe Cornejo, Creteur, Schuind and Taccone. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Kovacs, Matyas
Peluso, Lorenzo
Njimi, Hassane
De Witte, Olivier
Gouvêa Bogossian, Elisa
Quispe Cornejo, Armin
Creteur, Jacques
Schuind, Sophie
Taccone, Fabio Silvio
Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement
title Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement
title_full Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement
title_fullStr Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement
title_full_unstemmed Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement
title_short Optimal Cerebral Perfusion Pressure Guided by Brain Oxygen Pressure Measurement
title_sort optimal cerebral perfusion pressure guided by brain oxygen pressure measurement
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581172/
https://www.ncbi.nlm.nih.gov/pubmed/34777201
http://dx.doi.org/10.3389/fneur.2021.732830
work_keys_str_mv AT kovacsmatyas optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement
AT pelusolorenzo optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement
AT njimihassane optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement
AT dewitteolivier optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement
AT gouveabogossianelisa optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement
AT quispecornejoarmin optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement
AT creteurjacques optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement
AT schuindsophie optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement
AT tacconefabiosilvio optimalcerebralperfusionpressureguidedbybrainoxygenpressuremeasurement